By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sera Prognostics today announced the closing of a $19.3 million Series A financing, which it plans to use to complete a clinical trial and launch its test for predicting preterm birth.

The Salt Lake City firm also announced the appointment of Gregory Critchfield as its new CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.